0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Thin Films for Drug Delivery Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-28B16667
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Thin Films for Drug Delivery Market Research Report 2024
BUY CHAPTERS

Global Thin Films for Drug Delivery Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-28B16667
Report
November 2025
Pages:155
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Thin Films for Drug Delivery Market

The global Thin Films for Drug Delivery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Thin films for drug delivery are a promising pharmaceutical technology that involves the deposition of drug-loaded coatings onto surfaces, enabling controlled release of therapeutic agents. These films offer advantages such as precise dosing, targeted delivery, and improved patient compliance, making them suitable for various routes of administration including oral, transdermal, and ocular delivery. Thin film drug delivery systems are increasingly utilized in the pharmaceutical industry for their potential to enhance drug efficacy, reduce side effects, and optimize treatment outcomes.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Thin Films for Drug Delivery leading manufacturers including GSK, LTS Lohmann, Johnson & Johnson, Indivior, Pfizer, Sanofi, Church & Dwight, Adhex Pharma, Tapemark, Prestige Consumer Healthcare, etc., dominate supply; the top five capture approximately % of global revenue, with GSK leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Thin Films for Drug Delivery market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Thin Films for Drug Delivery Market Report

Report Metric Details
Report Name Thin Films for Drug Delivery Market
Segment by Type
  • Oral Thin Film
  • Transdermal Film
  • Others
Segment by Application
  • Hospitals
  • Drugstores
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, LTS Lohmann, Johnson & Johnson, Indivior, Pfizer, Sanofi, Church & Dwight, Adhex Pharma, Tapemark, Prestige Consumer Healthcare, Sun Pharma, MonoSol, Collegium Pharmaceutical, ARx, ZIM Labs, NAL Pharma, AdhexPharma, Aavishkar, IntelGenx, APR
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Thin Films for Drug Delivery study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Thin Films for Drug Delivery Market report?

Ans: The main players in the Thin Films for Drug Delivery Market are GSK, LTS Lohmann, Johnson & Johnson, Indivior, Pfizer, Sanofi, Church & Dwight, Adhex Pharma, Tapemark, Prestige Consumer Healthcare, Sun Pharma, MonoSol, Collegium Pharmaceutical, ARx, ZIM Labs, NAL Pharma, AdhexPharma, Aavishkar, IntelGenx, APR

What are the Application segmentation covered in the Thin Films for Drug Delivery Market report?

Ans: The Applications covered in the Thin Films for Drug Delivery Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Thin Films for Drug Delivery Market report?

Ans: The Types covered in the Thin Films for Drug Delivery Market report are Oral Thin Film, Transdermal Film, Others

1 Study Coverage
1.1 Introduction to Thin Films for Drug Delivery: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Thin Films for Drug Delivery Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Oral Thin Film
1.2.3 Transdermal Film
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Thin Films for Drug Delivery Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Thin Films for Drug Delivery Revenue Estimates and Forecasts 2020-2031
2.2 Global Thin Films for Drug Delivery Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Thin Films for Drug Delivery Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Thin Films for Drug Delivery Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Oral Thin Film Market Size by Players
3.3.2 Transdermal Film Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Thin Films for Drug Delivery Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Thin Films for Drug Delivery Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Thin Films for Drug Delivery Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Thin Films for Drug Delivery Market Size by Type (2020-2031)
6.4 North America Thin Films for Drug Delivery Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Thin Films for Drug Delivery Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Thin Films for Drug Delivery Market Size by Type (2020-2031)
7.4 Europe Thin Films for Drug Delivery Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Thin Films for Drug Delivery Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Thin Films for Drug Delivery Market Size by Type (2020-2031)
8.4 Asia-Pacific Thin Films for Drug Delivery Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Thin Films for Drug Delivery Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Thin Films for Drug Delivery Market Size by Type (2020-2031)
9.4 Central and South America Thin Films for Drug Delivery Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Thin Films for Drug Delivery Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Thin Films for Drug Delivery Market Size by Type (2020-2031)
10.4 Middle East and Africa Thin Films for Drug Delivery Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Thin Films for Drug Delivery Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Business Overview
11.1.3 GSK Thin Films for Drug Delivery Product Features and Attributes
11.1.4 GSK Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.1.5 GSK Thin Films for Drug Delivery Revenue by Product in 2024
11.1.6 GSK Thin Films for Drug Delivery Revenue by Application in 2024
11.1.7 GSK Thin Films for Drug Delivery Revenue by Geographic Area in 2024
11.1.8 GSK Thin Films for Drug Delivery SWOT Analysis
11.1.9 GSK Recent Developments
11.2 LTS Lohmann
11.2.1 LTS Lohmann Corporation Information
11.2.2 LTS Lohmann Business Overview
11.2.3 LTS Lohmann Thin Films for Drug Delivery Product Features and Attributes
11.2.4 LTS Lohmann Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.2.5 LTS Lohmann Thin Films for Drug Delivery Revenue by Product in 2024
11.2.6 LTS Lohmann Thin Films for Drug Delivery Revenue by Application in 2024
11.2.7 LTS Lohmann Thin Films for Drug Delivery Revenue by Geographic Area in 2024
11.2.8 LTS Lohmann Thin Films for Drug Delivery SWOT Analysis
11.2.9 LTS Lohmann Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Thin Films for Drug Delivery Product Features and Attributes
11.3.4 Johnson & Johnson Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.3.5 Johnson & Johnson Thin Films for Drug Delivery Revenue by Product in 2024
11.3.6 Johnson & Johnson Thin Films for Drug Delivery Revenue by Application in 2024
11.3.7 Johnson & Johnson Thin Films for Drug Delivery Revenue by Geographic Area in 2024
11.3.8 Johnson & Johnson Thin Films for Drug Delivery SWOT Analysis
11.3.9 Johnson & Johnson Recent Developments
11.4 Indivior
11.4.1 Indivior Corporation Information
11.4.2 Indivior Business Overview
11.4.3 Indivior Thin Films for Drug Delivery Product Features and Attributes
11.4.4 Indivior Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.4.5 Indivior Thin Films for Drug Delivery Revenue by Product in 2024
11.4.6 Indivior Thin Films for Drug Delivery Revenue by Application in 2024
11.4.7 Indivior Thin Films for Drug Delivery Revenue by Geographic Area in 2024
11.4.8 Indivior Thin Films for Drug Delivery SWOT Analysis
11.4.9 Indivior Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Thin Films for Drug Delivery Product Features and Attributes
11.5.4 Pfizer Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.5.5 Pfizer Thin Films for Drug Delivery Revenue by Product in 2024
11.5.6 Pfizer Thin Films for Drug Delivery Revenue by Application in 2024
11.5.7 Pfizer Thin Films for Drug Delivery Revenue by Geographic Area in 2024
11.5.8 Pfizer Thin Films for Drug Delivery SWOT Analysis
11.5.9 Pfizer Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Thin Films for Drug Delivery Product Features and Attributes
11.6.4 Sanofi Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.6.5 Sanofi Recent Developments
11.7 Church & Dwight
11.7.1 Church & Dwight Corporation Information
11.7.2 Church & Dwight Business Overview
11.7.3 Church & Dwight Thin Films for Drug Delivery Product Features and Attributes
11.7.4 Church & Dwight Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.7.5 Church & Dwight Recent Developments
11.8 Adhex Pharma
11.8.1 Adhex Pharma Corporation Information
11.8.2 Adhex Pharma Business Overview
11.8.3 Adhex Pharma Thin Films for Drug Delivery Product Features and Attributes
11.8.4 Adhex Pharma Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.8.5 Adhex Pharma Recent Developments
11.9 Tapemark
11.9.1 Tapemark Corporation Information
11.9.2 Tapemark Business Overview
11.9.3 Tapemark Thin Films for Drug Delivery Product Features and Attributes
11.9.4 Tapemark Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.9.5 Tapemark Recent Developments
11.10 Prestige Consumer Healthcare
11.10.1 Prestige Consumer Healthcare Corporation Information
11.10.2 Prestige Consumer Healthcare Business Overview
11.10.3 Prestige Consumer Healthcare Thin Films for Drug Delivery Product Features and Attributes
11.10.4 Prestige Consumer Healthcare Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Sun Pharma
11.11.1 Sun Pharma Corporation Information
11.11.2 Sun Pharma Business Overview
11.11.3 Sun Pharma Thin Films for Drug Delivery Product Features and Attributes
11.11.4 Sun Pharma Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.11.5 Sun Pharma Recent Developments
11.12 MonoSol
11.12.1 MonoSol Corporation Information
11.12.2 MonoSol Business Overview
11.12.3 MonoSol Thin Films for Drug Delivery Product Features and Attributes
11.12.4 MonoSol Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.12.5 MonoSol Recent Developments
11.13 Collegium Pharmaceutical
11.13.1 Collegium Pharmaceutical Corporation Information
11.13.2 Collegium Pharmaceutical Business Overview
11.13.3 Collegium Pharmaceutical Thin Films for Drug Delivery Product Features and Attributes
11.13.4 Collegium Pharmaceutical Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.13.5 Collegium Pharmaceutical Recent Developments
11.14 ARx
11.14.1 ARx Corporation Information
11.14.2 ARx Business Overview
11.14.3 ARx Thin Films for Drug Delivery Product Features and Attributes
11.14.4 ARx Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.14.5 ARx Recent Developments
11.15 ZIM Labs
11.15.1 ZIM Labs Corporation Information
11.15.2 ZIM Labs Business Overview
11.15.3 ZIM Labs Thin Films for Drug Delivery Product Features and Attributes
11.15.4 ZIM Labs Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.15.5 ZIM Labs Recent Developments
11.16 NAL Pharma
11.16.1 NAL Pharma Corporation Information
11.16.2 NAL Pharma Business Overview
11.16.3 NAL Pharma Thin Films for Drug Delivery Product Features and Attributes
11.16.4 NAL Pharma Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.16.5 NAL Pharma Recent Developments
11.17 AdhexPharma
11.17.1 AdhexPharma Corporation Information
11.17.2 AdhexPharma Business Overview
11.17.3 AdhexPharma Thin Films for Drug Delivery Product Features and Attributes
11.17.4 AdhexPharma Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.17.5 AdhexPharma Recent Developments
11.18 Aavishkar
11.18.1 Aavishkar Corporation Information
11.18.2 Aavishkar Business Overview
11.18.3 Aavishkar Thin Films for Drug Delivery Product Features and Attributes
11.18.4 Aavishkar Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.18.5 Aavishkar Recent Developments
11.19 IntelGenx
11.19.1 IntelGenx Corporation Information
11.19.2 IntelGenx Business Overview
11.19.3 IntelGenx Thin Films for Drug Delivery Product Features and Attributes
11.19.4 IntelGenx Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.19.5 IntelGenx Recent Developments
11.20 APR
11.20.1 APR Corporation Information
11.20.2 APR Business Overview
11.20.3 APR Thin Films for Drug Delivery Product Features and Attributes
11.20.4 APR Thin Films for Drug Delivery Revenue and Gross Margin (2020-2025)
11.20.5 APR Recent Developments
12 Thin Films for Drug DeliveryIndustry Chain Analysis
12.1 Thin Films for Drug Delivery Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Thin Films for Drug Delivery Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Thin Films for Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Thin Films for Drug Delivery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Thin Films for Drug Delivery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Thin Films for Drug Delivery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Thin Films for Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Thin Films for Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Thin Films for Drug Delivery Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Thin Films for Drug Delivery Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Thin Films for Drug Delivery by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thin Films for Drug Delivery as of 2024)
 Table 11. Global Thin Films for Drug Delivery Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Thin Films for Drug Delivery Companies Headquarters
 Table 13. Global Thin Films for Drug Delivery Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Thin Films for Drug Delivery Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Thin Films for Drug Delivery Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Thin Films for Drug Delivery Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Thin Films for Drug Delivery Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Thin Films for Drug Delivery High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Thin Films for Drug Delivery Growth Accelerators and Market Barriers
 Table 25. North America Thin Films for Drug Delivery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Thin Films for Drug Delivery Growth Accelerators and Market Barriers
 Table 27. Europe Thin Films for Drug Delivery Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Thin Films for Drug Delivery Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Thin Films for Drug Delivery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Thin Films for Drug Delivery Investment Opportunities and Key Challenges
 Table 31. Central and South America Thin Films for Drug Delivery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Thin Films for Drug Delivery Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Thin Films for Drug Delivery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. GSK Corporation Information
 Table 35. GSK Description and Major Businesses
 Table 36. GSK Product Features and Attributes
 Table 37. GSK Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. GSK Revenue Proportion by Product in 2024
 Table 39. GSK Revenue Proportion by Application in 2024
 Table 40. GSK Revenue Proportion by Geographic Area in 2024
 Table 41. GSK Thin Films for Drug Delivery SWOT Analysis
 Table 42. GSK Recent Developments
 Table 43. LTS Lohmann Corporation Information
 Table 44. LTS Lohmann Description and Major Businesses
 Table 45. LTS Lohmann Product Features and Attributes
 Table 46. LTS Lohmann Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. LTS Lohmann Revenue Proportion by Product in 2024
 Table 48. LTS Lohmann Revenue Proportion by Application in 2024
 Table 49. LTS Lohmann Revenue Proportion by Geographic Area in 2024
 Table 50. LTS Lohmann Thin Films for Drug Delivery SWOT Analysis
 Table 51. LTS Lohmann Recent Developments
 Table 52. Johnson & Johnson Corporation Information
 Table 53. Johnson & Johnson Description and Major Businesses
 Table 54. Johnson & Johnson Product Features and Attributes
 Table 55. Johnson & Johnson Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Johnson & Johnson Revenue Proportion by Product in 2024
 Table 57. Johnson & Johnson Revenue Proportion by Application in 2024
 Table 58. Johnson & Johnson Revenue Proportion by Geographic Area in 2024
 Table 59. Johnson & Johnson Thin Films for Drug Delivery SWOT Analysis
 Table 60. Johnson & Johnson Recent Developments
 Table 61. Indivior Corporation Information
 Table 62. Indivior Description and Major Businesses
 Table 63. Indivior Product Features and Attributes
 Table 64. Indivior Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Indivior Revenue Proportion by Product in 2024
 Table 66. Indivior Revenue Proportion by Application in 2024
 Table 67. Indivior Revenue Proportion by Geographic Area in 2024
 Table 68. Indivior Thin Films for Drug Delivery SWOT Analysis
 Table 69. Indivior Recent Developments
 Table 70. Pfizer Corporation Information
 Table 71. Pfizer Description and Major Businesses
 Table 72. Pfizer Product Features and Attributes
 Table 73. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Pfizer Revenue Proportion by Product in 2024
 Table 75. Pfizer Revenue Proportion by Application in 2024
 Table 76. Pfizer Revenue Proportion by Geographic Area in 2024
 Table 77. Pfizer Thin Films for Drug Delivery SWOT Analysis
 Table 78. Pfizer Recent Developments
 Table 79. Sanofi Corporation Information
 Table 80. Sanofi Description and Major Businesses
 Table 81. Sanofi Product Features and Attributes
 Table 82. Sanofi Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Sanofi Recent Developments
 Table 84. Church & Dwight Corporation Information
 Table 85. Church & Dwight Description and Major Businesses
 Table 86. Church & Dwight Product Features and Attributes
 Table 87. Church & Dwight Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Church & Dwight Recent Developments
 Table 89. Adhex Pharma Corporation Information
 Table 90. Adhex Pharma Description and Major Businesses
 Table 91. Adhex Pharma Product Features and Attributes
 Table 92. Adhex Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Adhex Pharma Recent Developments
 Table 94. Tapemark Corporation Information
 Table 95. Tapemark Description and Major Businesses
 Table 96. Tapemark Product Features and Attributes
 Table 97. Tapemark Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Tapemark Recent Developments
 Table 99. Prestige Consumer Healthcare Corporation Information
 Table 100. Prestige Consumer Healthcare Description and Major Businesses
 Table 101. Prestige Consumer Healthcare Product Features and Attributes
 Table 102. Prestige Consumer Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Prestige Consumer Healthcare Recent Developments
 Table 104. Sun Pharma Corporation Information
 Table 105. Sun Pharma Description and Major Businesses
 Table 106. Sun Pharma Product Features and Attributes
 Table 107. Sun Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Sun Pharma Recent Developments
 Table 109. MonoSol Corporation Information
 Table 110. MonoSol Description and Major Businesses
 Table 111. MonoSol Product Features and Attributes
 Table 112. MonoSol Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. MonoSol Recent Developments
 Table 114. Collegium Pharmaceutical Corporation Information
 Table 115. Collegium Pharmaceutical Description and Major Businesses
 Table 116. Collegium Pharmaceutical Product Features and Attributes
 Table 117. Collegium Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Collegium Pharmaceutical Recent Developments
 Table 119. ARx Corporation Information
 Table 120. ARx Description and Major Businesses
 Table 121. ARx Product Features and Attributes
 Table 122. ARx Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. ARx Recent Developments
 Table 124. ZIM Labs Corporation Information
 Table 125. ZIM Labs Description and Major Businesses
 Table 126. ZIM Labs Product Features and Attributes
 Table 127. ZIM Labs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. ZIM Labs Recent Developments
 Table 129. NAL Pharma Corporation Information
 Table 130. NAL Pharma Description and Major Businesses
 Table 131. NAL Pharma Product Features and Attributes
 Table 132. NAL Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. NAL Pharma Recent Developments
 Table 134. AdhexPharma Corporation Information
 Table 135. AdhexPharma Description and Major Businesses
 Table 136. AdhexPharma Product Features and Attributes
 Table 137. AdhexPharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. AdhexPharma Recent Developments
 Table 139. Aavishkar Corporation Information
 Table 140. Aavishkar Description and Major Businesses
 Table 141. Aavishkar Product Features and Attributes
 Table 142. Aavishkar Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Aavishkar Recent Developments
 Table 144. IntelGenx Corporation Information
 Table 145. IntelGenx Description and Major Businesses
 Table 146. IntelGenx Product Features and Attributes
 Table 147. IntelGenx Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. IntelGenx Recent Developments
 Table 149. APR Corporation Information
 Table 150. APR Description and Major Businesses
 Table 151. APR Product Features and Attributes
 Table 152. APR Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. APR Recent Developments
 Table 154. Raw Materials Key Suppliers
 Table 155. Distributors List
 Table 156. Market Trends and Market Evolution
 Table 157. Market Drivers and Opportunities
 Table 158. Market Challenges, Risks, and Restraints
 Table 159. Research Programs/Design for This Report
 Table 160. Key Data Information from Secondary Sources
 Table 161. Key Data Information from Primary Sources


List of Figures
 Figure 1. Thin Films for Drug Delivery Product Picture
 Figure 2. Global Thin Films for Drug Delivery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Oral Thin Film Product Picture
 Figure 4. Transdermal Film Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Thin Films for Drug Delivery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospitals
 Figure 8. Drugstores
 Figure 9. Others
 Figure 10. Thin Films for Drug Delivery Report Years Considered
 Figure 11. Global Thin Films for Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Thin Films for Drug Delivery Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Thin Films for Drug Delivery Revenue Market Share by Region (2020-2031)
 Figure 15. Global Thin Films for Drug Delivery Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Oral Thin Film Revenue Market Share by Player in 2024
 Figure 18. Transdermal Film Revenue Market Share by Player in 2024
 Figure 19. Others Revenue Market Share by Player in 2024
 Figure 20. Global Thin Films for Drug Delivery Revenue Market Share by Type (2020-2031)
 Figure 21. Global Thin Films for Drug Delivery Revenue Market Share by Application (2020-2031)
 Figure 22. North America Thin Films for Drug Delivery Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Thin Films for Drug Delivery Revenue (US$ Million) in 2024
 Figure 24. North America Thin Films for Drug Delivery Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Thin Films for Drug Delivery Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Thin Films for Drug Delivery Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Thin Films for Drug Delivery Revenue (US$ Million) in 2024
 Figure 31. Europe Thin Films for Drug Delivery Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Thin Films for Drug Delivery Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 34. France Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Thin Films for Drug Delivery Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Thin Films for Drug Delivery Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Thin Films for Drug Delivery Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Thin Films for Drug Delivery Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 46. India Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Thin Films for Drug Delivery Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Thin Films for Drug Delivery Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Thin Films for Drug Delivery Revenue (US$ Million) in 2024
 Figure 54. Central and South America Thin Films for Drug Delivery Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Thin Films for Drug Delivery Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Thin Films for Drug Delivery Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Thin Films for Drug Delivery Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Thin Films for Drug Delivery Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Thin Films for Drug Delivery Revenue (US$ Million) in 2024
 Figure 60. South America Thin Films for Drug Delivery Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Thin Films for Drug Delivery Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Thin Films for Drug Delivery Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Thin Films for Drug Delivery Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Thin Films for Drug Delivery Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Thin Films for Drug Delivery Revenue (2020-2025) & (US$ Million)
 Figure 66. Thin Films for Drug Delivery Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart